Medikinet Cr

Methylphenidate Hydrochloride, the active ingredient in Medikinet Cr, is a central nervous system stimulant presented as an oral tablet for oral use. It treats attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults, helping improve focus and reduce hyperactivity. GNH USA supplies Medikinet Cr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medikinet Cr is a central nervous system stimulant indicated for the following conditions: - Attention deficit hyperactivity disorder (ADHD): improves attention, reduces impulsivity and hyperactivity in diagnosed patients. - Narcolepsy: helps maintain wakefulness and reduces excessive daytime sleepiness. - Attention deficit disorder (ADD): increases concentration and supports daily functioning in individuals with this diagnosis.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Stomach pain or nausea: gastrointestinal discomfort. - Headache: mild to moderate head pain. - Increased heart rate: tachycardia or palpitations. - Irritability or mood swings.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, arrhythmia, or chest pain. - Psychosis: hallucinations or delusional thinking. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Growth suppression: prolonged impact on height in children. - Seizures: increased risk in susceptible individuals.

When prescribing Medikinet Cr, consider the following precautions: - Cardiovascular assessment: evaluate heart disease or hypertension before initiating therapy. - Psychiatric history: monitor for new or worsening anxiety, agitation, or psychotic symptoms. - Growth monitoring: regularly assess height and weight in pediatric patients. - Potential for abuse: use with caution in individuals with a history of substance misuse. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Medikinet Cr may interact with several other medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: methylphenidate can diminish blood‑pressure‑lowering effects. - Anticonvulsants: may alter methylphenidate plasma levels. - CYP2D6 inhibitors: can increase methylphenidate concentrations, requiring dose adjustment.